PURPOSE: Postcardiotomy cardiogenic shock is still associated with a poor prognosis. We reviewed patients undergoing extracorporeal membrane oxygenation (ECMO) support for postcardiotomy cardiogenic shock and assessed their long-term outcomes. METHODS: The subjects were 47 patients who received ECMO support for cardiogenic shock after open heart surgery. We analyzed the long-term survival and risk factors for early or late death. RESULTS: Twenty-nine patients were weaned off ECMO support, but 15 of these patients died during their hospital stay. An independent predictor of mortality during ECMO support was incomplete sternum closure (OR 4.089, 95 % CL 1.003-16.67, p = 0.049) and a predictor of mortality after weaning off ECMO was more than 48 h of support (OR 8.975, 95 % CL 1.281-62.896, p = 0.027). Fourteen patients were discharged from hospital, but seven of these patients died during the follow-up period owing to cardiac events (n = 2) or non-cardiac causes (n = 5). The actuarial survival rates were 34.0 % at 30 days, 29.8 % at 1 year, and 17.6 % at 10 years. CONCLUSION: Although postcardiotomy cardiogenic shock requiring ECMO support is associated with high morbidity and mortality, the long-term survival rate is acceptable.
PURPOSE:Postcardiotomy cardiogenic shock is still associated with a poor prognosis. We reviewed patients undergoing extracorporeal membrane oxygenation (ECMO) support for postcardiotomy cardiogenic shock and assessed their long-term outcomes. METHODS: The subjects were 47 patients who received ECMO support for cardiogenic shock after open heart surgery. We analyzed the long-term survival and risk factors for early or late death. RESULTS: Twenty-nine patients were weaned off ECMO support, but 15 of these patients died during their hospital stay. An independent predictor of mortality during ECMO support was incomplete sternum closure (OR 4.089, 95 % CL 1.003-16.67, p = 0.049) and a predictor of mortality after weaning off ECMO was more than 48 h of support (OR 8.975, 95 % CL 1.281-62.896, p = 0.027). Fourteen patients were discharged from hospital, but seven of these patients died during the follow-up period owing to cardiac events (n = 2) or non-cardiac causes (n = 5). The actuarial survival rates were 34.0 % at 30 days, 29.8 % at 1 year, and 17.6 % at 10 years. CONCLUSION: Although postcardiotomy cardiogenic shock requiring ECMO support is associated with high morbidity and mortality, the long-term survival rate is acceptable.
Authors: N G Smedira; N Moazami; C M Golding; P M McCarthy; C Apperson-Hansen; E H Blackstone; D M Cosgrove Journal: J Thorac Cardiovasc Surg Date: 2001-07 Impact factor: 5.209
Authors: M Hata; M Shiono; Y Orime; S Y Yagi; T Yamamoto; H Okumura; S I Kimura; K I Nakata; S Kashiwazaki; S Choh; N Negishi; Y Sezai Journal: Artif Organs Date: 2000-08 Impact factor: 3.094
Authors: D D Muehrcke; P M McCarthy; R W Stewart; S Seshagiri; D A Ogella; R C Foster; D M Cosgrove Journal: J Thorac Cardiovasc Surg Date: 1995-09 Impact factor: 5.209
Authors: Paolo Meani; Matteo Matteucci; Federica Jiritano; Dario Fina; Francesco Panzeri; Giuseppe M Raffa; Mariusz Kowalewski; Nuccia Morici; Giovanna Viola; Alice Sacco; Fabrizio Oliva; Amal Alyousif; Sam Heuts; Martijn Gilbers; Rick Schreurs; Jos Maessen; Roberto Lorusso Journal: Ann Cardiothorac Surg Date: 2019-01
Authors: Carrie L Freeman; Tellen D Bennett; T Charles Casper; Gitte Y Larsen; Ania Hubbard; Jacob Wilkes; Susan L Bratton Journal: Crit Care Med Date: 2014-03 Impact factor: 7.598
Authors: Roberto Lorusso; Giuseppe Maria Raffa; Khalid Alenizy; Niels Sluijpers; Maged Makhoul; Daniel Brodie; Mike McMullan; I-Wen Wang; Paolo Meani; Graeme MacLaren; Mariusz Kowalewski; Heidi Dalton; Ryan Barbaro; Xiaotong Hou; Nicholas Cavarocchi; Yih-Sharng Chen; Ravi Thiagarajan; Peta Alexander; Bahaaldin Alsoufi; Christian A Bermudez; Ashish S Shah; Jonathan Haft; David A D'Alessandro; Udo Boeken; Glenn J R Whitman Journal: J Heart Lung Transplant Date: 2019-08-10 Impact factor: 10.247
Authors: Priya R Menon; Anna Flo Forner; Mateo Marin-Cuartas; Sven Lehmann; Diyar Saeed; André Ginther; Michael A Borger; Jörg Ender Journal: Interact Cardiovasc Thorac Surg Date: 2021-05-10
Authors: Paolo Meani; Thijs Delnoij; Giuseppe M Raffa; Nuccia Morici; Giovanna Viola; Alice Sacco; Fabrizio Oliva; Sam Heuts; Jan-Willem Sels; Rob Driessen; Paul Roekaerts; Martijn Gilbers; Elham Bidar; Rick Schreurs; Ehsan Natour; Leo Veenstra; Suzanne Kats; Jos Maessen; Roberto Lorusso Journal: Perfusion Date: 2018-07-19 Impact factor: 1.972
Authors: Maged Makhoul; Samuel Heuts; Abdulrahman Mansouri; Fabio Silvio Taccone; Amir Obeid; Belliato Mirko; Lars Mikael Broman; Maximilian Valentin Malfertheiner; Paolo Meani; Giuseppe Maria Raffa; Thijs Delnoij; Jos Maessen; Gil Bolotin; Roberto Lorusso Journal: Artif Organs Date: 2021-07-06 Impact factor: 3.094